Surmodics (SRDX) Earnings Date, Estimates & Call Transcripts $35.60 -0.43 (-1.20%) As of 03:16 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Surmodics Earnings Summary Surmodics released Q2 2025 earnings on April 30, 2025, reporting an EPS of -$0.13, which missed analysts' consensus estimates of -$0.06 by $0.07. Quarterly revenue was reported to be $28.09 million, below analyst estimates of $32.23 million. With a trailing EPS of -$1.39, Surmodics' earnings are expected to grow 300.00% next year, from $0.20 to $0.80 per share. Upcoming Q3 Earnings DateAug. 6Before Market OpensEstimatedConsensus EPS (Apr. 30) -$0.06 Actual EPS (Apr. 30) -$0.13 Missed By -$0.07 Actual Revenue (Apr. 30) $28.09MQ2 2025 Earnings ResourcesQ2 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)SRDX Upcoming EarningsSurmodics' Q3 2025 earnings is scheduled for Wednesday, August 6, 2025Powered by Get Surmodics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Surmodics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataSRDX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SRDX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Surmodics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany EPS GuidanceCompany Revenue GuidanceQ1 20252-$0.11-$0.09-$0.10Q2 20252-$0.04$0.00-$0.02Q3 20252-$0.21-$0.21-$0.21Q4 20252-$0.18-$0.18-$0.18 FY 2025 8 -$0.54 -$0.48 -$0.51 Q1 20262-$0.18-$0.18-$0.18Q2 20262$0.01$0.01$0.01Q3 20262$0.01$0.01$0.01Q4 20262$0.07$0.07$0.07 FY 2026 8 -$0.09 -$0.09 -$0.09 Q1 20271$0.00$0.00$0.00Q2 20271$0.11$0.11$0.11 Surmodics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/6/2025(Estimated)--------4/30/2025Q2 2025-$0.06-$0.13 -$0.07-$0.36$32.23M$28.09M2/6/2025Q1 2025-$0.08-$0.04+$0.04-$0.26$33.37M-11/6/2024--$0.27-$0.13+$0.14-$0.02$30.69M$33.23M7/31/2024Q3 2024-$0.31-$0.27+$0.04-$0.01$30.32M$30.34M5/1/2024Q2 2024-$0.36$0.07+$0.43$0.12$28.79M$31.96M11/8/2023Q4 2023$0.16$0.53+$0.37$0.59$26.00M$27.97M Surmodics Earnings - Frequently Asked Questions When is Surmodics' earnings date? Surmodics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 6th, 2025 based off last year's report dates. Learn more on SRDX's earnings history. Did Surmodics beat their earnings estimates last quarter? In the previous quarter, Surmodics (NASDAQ:SRDX) missed the analysts' consensus estimate of ($0.06) by $0.07 with a reported earnings per share (EPS) of ($0.13). Learn more on analysts' earnings estimate vs. SRDX's actual earnings. How much revenue does Surmodics generate each year? Surmodics (NASDAQ:SRDX) has a recorded annual revenue of $121.58 million. How much profit does Surmodics generate each year? Surmodics (NASDAQ:SRDX) has a recorded net income of -$11.54 million. SRDX has generated -$1.39 earnings per share over the last four quarters. What is Surmodics' EPS forecast for next year? Surmodics' earnings are expected to grow from $0.20 per share to $0.80 per share in the next year, which is a 300.00% increase. More Earnings Resources from MarketBeat Related Companies Alphatec Earnings Results AtriCure Earnings Results Integra LifeSciences Earnings Results Orthofix Medical Earnings Results AngioDynamics Earnings Results Accuray Earnings Results Rockwell Medical Earnings Results ReShape Lifesciences Earnings Results Abbott Laboratories Earnings Results Intuitive Surgical Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon's Earnings: What Comes Next and How to Play ItApple Stock: Big Earnings, Small Move—Time to Buy?Why Robinhood Just Added Upside Potential After a Q2 Earnings DipMicrosoft Blasts Past Earnings—What’s Next for MSFT?Visa Beats Q3 Earnings Expectations, So Why Did the Market Panic?Spotify's Q2 Earnings Plunge: An Opportunity or Ominous Signal?RCL Stock Sinks After Earnings—Is a Buying Opportunity Ahead? This page (NASDAQ:SRDX) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surmodics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surmodics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SRDX Stock Alerts